Research Article
Impact of Cusp-Overlap View for TAVR with Self-Expandable Valves on 30-Day Conduction Disturbances
Table 1
Population characteristics.
| | | CON group, n = 101 (%) | COVL group, n = 156 (%) | |
| | Age (years) | 79.8 ± 7.9 | 79.6 ± 7.4 | 0.9 | | Male | 49 (48.5) | 79 (50.6) | 0.73 | | Hypertension | 90 (89.1) | 138 (88.4) | 0.89 | | Diabetes | 21 (20.8) | 33 (21.1) | 0.94 | | Dyslipidemia | 69 (68.3) | 107 (68.5) | 0.96 | | Previous AMI | 23 (22.7) | 36 (23.1) | 0.92 | | Previous CABG | 19 (18.8) | 31 (19.9) | 0.83 | | Previous PCI | 32 (31.7) | 46 (29.5) | 0.45 | | PCI before TVAR (<3 months) | 22 (21.8) | 31 (19.9) | 0.71 | | Stroke | 5 (4.9) | 4 (2.6) | 0.30 | | COPD | 19 (18.8) | 31 (18.9) | 0.83 | | eGFR (ml/min) | 60.1 ± 19.3 | 60.3 ± 18.9 | 0.82 | | eGFR <60 ml/min | 25 (24.7) | 37 (23.7) | 0.64 | | eGFR <45 ml/min | 11 (10.9) | 16 (10.2) | 0.87 | | Dialysis | 3 (3) | 1 (0.6) | 0.14 | | STS | 5.8 ± 2.4 | 5.9 ± 2.6 | 0.80 | | Prior atrial fibrillation | 16 (15.8) | 26 (16.7) | 0.86 | | Prior RBBB | 10 (9.9) | 18 (11.5) | 0.68 | | Prior LBBB | 10 (9.9) | 15 (9.6) | 0.93 | | Prior first-degree atrioventricular block | 1 (0.9) | 3 (1.9) | 0.55 | | LVEF (%) | 54.8 ± 10.4 | 55.1 ± 10.9 | 0.90 | | LVEF <35% | 11 (10.9) | 19 (12.2) | 0.75 | | Aortic valve area (mm2) | 0.71 ± 0.19 | 0.72 ± 0.18 | 0.90 | | Mean gradient | 40.2 ± 10.7 | 40.9 ± 11.2 | 0.87 | | LVOT calcification | 6 (5.94) | 8 (5.18) | 0.77 | | Severity of aortic valve calcification | 3231.2 ± 1040.3 | 3298.6 ± 916.5 | 0.09 |
|
|
